美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

UpStream Bio Inc.

6.41

+0.01000.16%

盘后：6.410.00000.00%19:34 EDT

成交量：62.64万

成交额：398.82万

市值：3.49亿

市盈率：-2.21

高：6.61

开：6.40

低：6.16

收：6.40

52周最高：33.68

52周最低：5.85

股本：5,442.00万

流通股本：4,073.26万

量比：1.25

换手率：1.54%

股息：- -

股息率：- -

每股收益(TTM):-2.9013

每股收益(LYR):-2.6636

净资产收益率：-41.83%

总资产收益率：-27.76%

市净率：1.15

市盈率(LYR):-2.41

数据加载中...

总览公司新闻公告

Upstream Bio在EAACI 2026大会上公布新应答者分析：Verekitug在二期VIBRANT试验中为绝大多数CRSwNP患者带来具临床意义的改善

美国研究综述-Adobe、Caseys General Stores、Oracle

上游生物将在EAACI 2026口头报告环节展示Verekitug针对CRSwNP的二期Vibrant试验额外疗效数据

Upstream Bio在ATS 2026国际会议上公布Verekitug二期Vibrant试验新数据，显示其改善CRSwNP合并哮喘患者的哮喘症状控制

Upstream Bio Inc与Leerink Partners达成普通股销售协议拟融资1.5亿美元——SEC文件披露

Upstream Bio公布Verekitug三期临床试验战略及2025年第四季度与全年财务业绩

Upstream Bio, Inc.盘中异动早盘股价大涨5.30%报8.55美元

Upstream Bio在2026年AAAAI年会上公布Verekitug治疗慢性鼻窦炎伴鼻息肉的2期Vibrant试验补充分析结果

BUZZ--美国股票走势-麦当劳、Cloudflare、黄金矿商

BUZZ-实验性哮喘药物在中期研究中显示出前景，上游生物一跃而起

Upstream Bio公布Verekitug治疗重症哮喘II期Valiant试验积极顶线结果

Upstream Bio, Inc.盘中异动大幅上涨5.07%报27.45美元

Upstream Bio, Inc.盘中异动早盘股价大跌5.03%报29.24美元

Upstream Bio, Inc.盘中异动股价大跌5.12%

Upstream Bio, Inc.盘中异动临近午盘股价大跌5.06%报30.18美元

Upstream Bio, Inc.盘中异动股价大跌5.06%报25.70美元

Upstream Bio, Inc.盘中异动早盘急速上涨5.31%

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/UPB/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"UPB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"UPB\",,,,,undefined,":{"symbol":"UPB","market":"US","secType":"STK","nameCN":"UpStream Bio Inc.","latestPrice":6.41,"timestamp":1784923200000,"preClose":6.4,"halted":0,"volume":626431,"hourTrading":{"tag":"盘后","latestPrice":6.41,"preClose":6.41,"latestTime":"19:34 EDT","volume":16818,"amount":106794.1095,"timestamp":1784936047895,"change":0,"changeRate":0,"amplitude":0.048362},"delay":0,"changeRate":0.0015624999999999667,"floatShares":40732635,"shares":54419986,"eps":-2.901349,"marketStatus":"休市中","change":0.01,"latestTime":"07-24 16:00:00 EDT","open":6.4,"high":6.61,"low":6.16,"amount":3988199.898033,"amplitude":0.070313,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.901349,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1785139200000},"marketStatusCode":7,"adr":0,"listingDate":1728619200000,"exchange":"NASDAQ","adjPreClose":6.4,"postHourTrading":{"tag":"盘后","latestPrice":6.41,"preClose":6.41,"latestTime":"19:34 EDT","volume":16818,"amount":106794.1095,"timestamp":1784936047895,"change":0,"changeRate":0,"amplitude":0.048362},"volumeRatio":1.249023501026606,"impliedVol":3.7402,"impliedVolPercentile":0.9562},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"UPB\",,,,,undefined,":{"symbol":"UPB","floatShares":40732635,"roa":"-27.76%","roe":"-41.83%","lyrEps":-2.663615,"volumeRatio":1.249023501026606,"shares":54419986,"dividePrice":0,"high":6.61,"amplitude":0.070313,"preClose":6.4,"low":6.16,"week52Low":5.85,"pbRate":"1.15","psRate":"105.01","week52High":33.68,"institutionHeld":0,"latestPrice":6.41,"eps":-2.901349,"divideRate":0,"volume":626431,"delay":0,"ttmEps":-2.901349,"open":6.4,"prevYearClose":27.15,"prevWeekClose":7.01,"prevMonthClose":6.92,"prevQuarterClose":6.92,"fiveDayClose":7.01,"twentyDayClose":6.36,"sixtyDayClose":9.51},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/UPB\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-05-13","symbol":"UPB","fiscalQuarterEnding":"2026/03","expectedEps":-0.8,"name":null,"time":"盘前","type":"earning","dateTimestamp":1778644800000,"reportTimeType":"pre","actualEps":-0.75},{"market":"US","date":"2026-03-26","symbol":"UPB","fiscalQuarterEnding":"2025/12","expectedEps":-0.73,"name":null,"time":"盘前","type":"earning","dateTimestamp":1774497600000,"reportTimeType":"pre","actualEps":-0.79},{"market":"US","date":"2025-05-06","symbol":"UPB","fiscalQuarterEnding":"2025/03","expectedEps":-0.49,"name":null,"time":"盘前","type":"earning","dateTimestamp":1746504000000,"reportTimeType":"pre","actualEps":-0.51},{"market":"US","date":"2025-03-12","symbol":"UPB","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盘前","type":"earning","dateTimestamp":1741752000000,"reportTimeType":"pre","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"UPB\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"UPB\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1111,"buy":0.6667,"hold":0.2222,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":9,"updateTime":1781323200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/UPB\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"UPB","date":"2026-07-24","current":-2.209317,"percent":0.975281,"low":-36.237602,"twenty":-12.962966,"median":-8.408673,"eighty":-3.733139,"high":-2.055104,"avg":-9.900784,"sd":6.987376,"marketCap":348287910},"quantilePoints":[{"date":"2024-10-11","current":-21.547111,"twenty":-21.096119,"median":-20.419631,"eighty":-19.743142,"marketCap":872808815},{"date":"2024-10-18","current":-29.91246,"twenty":-29.856691,"median":-29.151973,"eighty":-22.814588,"marketCap":1211664002},{"date":"2024-10-25","current":-33.154958,"twenty":-33.128498,"median":-29.931472,"eighty":-28.137991,"marketCap":1343007876},{"date":"2024-10-31","current":-32.943274,"twenty":-33.154958,"median":-32.429578,"eighty":-29.151973,"marketCap":1334433205},{"date":"2024-11-08","current":-35.748083,"twenty":-33.28726,"median":-32.943274,"eighty":-29.633615,"marketCap":1448047598},{"date":"2024-11-15","current":-26.036965,"twenty":-33.27403,"median":-32.40745,"eighty":-26.47861,"marketCap":1390295829},{"date":"2024-11-22","current":-17.866537,"twenty":-33.154958,"median":-29.91246,"eighty":-25.555171,"marketCap":954019497},{"date":"2024-11-29","current":-21.951751,"twenty":-33.154958,"median":-29.151973,"eighty":-21.870823,"marketCap":1172157663},{"date":"2024-12-06","current":-22.082237,"twenty":-33.144374,"median":-26.689395,"eighty":-21.903572,"marketCap":1179125222},{"date":"2024-12-13","current":-20.486294,"twenty":-33.088806,"median":-26.036965,"eighty":-21.589777,"marketCap":1093906626},{"date":"2024-12-20","current":-16.672089,"twenty":-32.969734,"median":-24.742143,"eighty":-20.201232,"marketCap":890239542},{"date":"2024-12-27","current":-19.517686,"twenty":-32.858694,"median":-23.382078,"eighty":-19.472518,"marketCap":1042185906},{"date":"2025-01-03","current":-16.36093,"twenty":-32.784605,"median":-22.553994,"eighty":-19.153329,"marketCap":873624596},{"date":"2025-01-10","current":-16.250519,"twenty":-32.617811,"median":-22.077219,"eighty":-18.486847,"marketCap":867728970},{"date":"2025-01-17","current":-10.92067,"twenty":-31.635576,"median":-21.951751,"eighty":-17.320504,"marketCap":583131018},{"date":"2025-01-24","current":-10.810259,"twenty":-29.950484,"median":-21.600443,"eighty":-16.501454,"marketCap":577235392},{"date":"2025-01-31","current":-11.041119,"twenty":-29.91246,"median":-20.852659,"eighty":-16.230444,"marketCap":589562611},{"date":"2025-02-07","current":-8.561886,"twenty":-29.633615,"median":-19.703378,"eighty":-11.472726,"marketCap":457179006},{"date":"2025-02-14","current":-7.3574,"twenty":-29.151973,"median":-19.472518,"eighty":-10.92067,"marketCap":392863085},{"date":"2025-02-21","current":-8.260764,"twenty":-28.137991,"median":-19.276941,"eighty":-10.810259,"marketCap":441100026},{"date":"2025-02-28","current":-7.839194,"twenty":-27.097043,"median":-19.030874,"eighty":-9.965112,"marketCap":418589453},{"date":"2025-03-07","current":-8.451474,"twenty":-26.562924,"median":-18.338294,"eighty":-8.834903,"marketCap":451283380},{"date":"2025-03-14","current":-7.737899,"twenty":-26.318012,"median":-17.866537,"eighty":-8.491624,"marketCap":485986508},{"date":"2025-03-21","current":-6.875286,"twenty":-26.085144,"median":-16.857781,"eighty":-8.411325,"marketCap":431809204},{"date":"2025-03-28","current":-5.816236,"twenty":-26.012875,"median":-16.36093,"eighty":-8.168077,"marketCap":365294494},{"date":"2025-04-04","current":-5.380659,"twenty":-25.645507,"median":-16.240482,"eighty":-7.936302,"marketCap":337937638},{"date":"2025-04-11","current":-5.466066,"twenty":-24.254326,"median":-13.751211,"eighty":-7.734483,"marketCap":343301728},{"date":"2025-04-17","current":-7.191293,"twenty":-23.886958,"median":-11.472726,"eighty":-7.5722,"marketCap":451656335},{"date":"2025-04-25","current":-7.652492,"twenty":-23.286723,"median":-11.041119,"eighty":-7.514132,"marketCap":480622419},{"date":"2025-05-02","current":-7.693506,"twenty":-22.857123,"median":-10.850408,"eighty":-7.502769,"marketCap":483198327},{"date":"2025-05-09","current":-6.005612,"twenty":-22.499792,"median":-10.810259,"eighty":-7.378434,"marketCap":475536334},{"date":"2025-05-16","current":-5.964849,"twenty":-22.162536,"median":-10.288315,"eighty":-7.189481,"marketCap":472308712},{"date":"2025-05-23","current":-6.324914,"twenty":-22.076215,"median":-9.921951,"eighty":-6.77963,"marketCap":500819374},{"date":"2025-05-30","current":-6.352089,"twenty":-22.02402,"median":-9.013568,"eighty":-6.524152,"marketCap":502971123},{"date":"2025-06-06","current":-7.357554,"twenty":-21.951751,"median":-8.668839,"eighty":-6.524152,"marketCap":582585803},{"date":"2025-06-13","current":-7.853492,"twenty":-21.855392,"median":-8.531773,"eighty":-6.551855,"marketCap":621855206},{"date":"2025-06-20","current":-7.228474,"twenty":-21.688772,"median":-8.441437,"eighty":-6.588317,"marketCap":572364999},{"date":"2025-06-27","current":-7.432284,"twenty":-21.589777,"median":-8.421362,"eighty":-6.683973,"marketCap":588503110},{"date":"2025-07-03","current":-7.60892,"twenty":-21.547111,"median":-8.293047,"eighty":-6.875286,"marketCap":602489473},{"date":"2025-07-11","current":-8.043715,"twenty":-21.219023,"median":-8.229183,"eighty":-7.004282,"marketCap":636917443},{"date":"2025-07-18","current":-7.500221,"twenty":-20.486294,"median":-8.00983,"eighty":-7.116503,"marketCap":593882481},{"date":"2025-07-25","current":-9.06956,"twenty":-20.325696,"median":-7.964314,"eighty":-7.165671,"marketCap":718145935},{"date":"2025-08-01","current":-10.401121,"twenty":-19.703378,"median":-8.043715,"eighty":-7.186764,"marketCap":823581592},{"date":"2025-08-08","current":-8.173881,"twenty":-19.517686,"median":-8.19076,"eighty":-7.191293,"marketCap":853925323},{"date":"2025-08-15","current":-9.608438,"twenty":-19.472518,"median":-8.256445,"eighty":-7.228474,"marketCap":1003793530},{"date":"2025-08-22","current":-9.154334,"twenty":-19.472518,"median":-8.332111,"eighty":-7.228474,"marketCap":956353234},{"date":"2025-08-29","current":-8.648626,"twenty":-19.29215,"median":-8.429698,"eighty":-7.242061,"marketCap":903521996},{"date":"2025-09-05","current":-10.155428,"twenty":-19.267816,"median":-8.442215,"eighty":-7.274671,"marketCap":1060937523},{"date":"2025-09-12","current":-9.247219,"twenty":-19.117195,"median":-8.531282,"eighty":-7.282823,"marketCap":966056931},{"date":"2025-09-19","current":-8.911801,"twenty":-19.040911,"median":-8.561886,"eighty":-7.298422,"marketCap":931015804},{"date":"2025-09-26","current":-8.416414,"twenty":-18.814066,"median":-8.561394,"eighty":-7.303028,"marketCap":879262754},{"date":"2025-10-03","current":-9.592957,"twenty":-18.486847,"median":-8.591998,"eighty":-7.324944,"marketCap":1002176247},{"date":"2025-10-10","current":-10.212191,"twenty":-18.290115,"median":-8.630565,"eighty":-7.351996,"marketCap":1066867560},{"date":"2025-10-17","current":-11.4971,"twenty":-18.113457,"median":-8.648626,"eighty":-7.357523,"marketCap":1201102033},{"date":"2025-10-24","current":-10.903668,"twenty":-17.908694,"median":-8.694854,"eighty":-7.362988,"marketCap":1139106192},{"date":"2025-10-31","current":-13.298037,"twenty":-17.320504,"median":-8.903157,"eighty":-7.366819,"marketCap":1389245933},{"date":"2025-11-07","current":-10.460565,"twenty":-17.071577,"median":-8.919541,"eighty":-7.375835,"marketCap":1278553063},{"date":"2025-11-14","current":-10.319087,"twenty":-16.746366,"median":-8.953083,"eighty":-7.3842,"marketCap":1261260713},{"date":"2025-11-21","current":-11.035322,"twenty":-16.535581,"median":-9.042102,"eighty":-7.390371,"marketCap":1348803231},{"date":"2025-11-28","current":-12.644639,"twenty":-16.41714,"median":-9.068084,"eighty":-7.395598,"marketCap":1545503702},{"date":"2025-12-05","current":-12.264416,"twenty":-16.306728,"median":-9.154334,"eighty":-7.402392,"marketCap":1499030514},{"date":"2025-12-12","current":-12.145044,"twenty":-16.258549,"median":-9.253501,"eighty":-7.413262,"marketCap":1484440094},{"date":"2025-12-19","current":-13.201711,"twenty":-16.238474,"median":-9.412348,"eighty":-7.419454,"marketCap":1613592327},{"date":"2025-12-26","current":-13.38298,"twenty":-16.206354,"median":-9.577476,"eighty":-7.422171,"marketCap":1635748149},{"date":"2026-01-02","current":-12.003565,"twenty":-15.686418,"median":-9.608438,"eighty":-7.426849,"marketCap":1467147745},{"date":"2026-01-09","current":-12.175992,"twenty":-13.691713,"median":-9.623919,"eighty":-7.437719,"marketCap":1488222796},{"date":"2026-01-16","current":-13.661516,"twenty":-14.223893,"median":-9.706483,"eighty":-7.459459,"marketCap":1669792461},{"date":"2026-01-23","current":-14.055003,"twenty":-14.055003,"median":-9.763246,"eighty":-7.459459,"marketCap":1717886807},{"date":"2026-01-30","current":-13.679201,"twenty":-14.055003,"median":-9.837934,"eighty":-7.487886,"marketCap":1671954005},{"date":"2026-02-06","current":-11.495127,"twenty":-13.997527,"median":-9.967119,"eighty":-7.498759,"marketCap":1405003366},{"date":"2026-02-13","current":-5.659139,"twenty":-13.966579,"median":-10.045793,"eighty":-7.487886,"marketCap":691693964},{"date":"2026-02-20","current":-3.775707,"twenty":-13.794285,"median":-9.921951,"eighty":-7.430925,"marketCap":461489567},{"date":"2026-02-27","current":-3.49275,"twenty":-13.743121,"median":-9.768407,"eighty":-7.40375,"marketCap":426904868},{"date":"2026-03-06","current":-3.391062,"twenty":-13.712802,"median":-9.724309,"eighty":-7.375835,"marketCap":414475992},{"date":"2026-03-13","current":-4.171405,"twenty":-13.705728,"median":-9.63424,"eighty":-7.351996,"marketCap":509854106},{"date":"2026-03-20","current":-3.704968,"twenty":-13.684506,"median":-9.611018,"eighty":-7.282823,"marketCap":452843392},{"date":"2026-03-27","current":-3.71417,"twenty":-13.665053,"median":-9.577476,"eighty":-7.221038,"marketCap":532771662},{"date":"2026-04-02","current":-3.532065,"twenty":-13.632336,"median":-9.412348,"eighty":-7.146004,"marketCap":506650069},{"date":"2026-04-10","current":-3.953182,"twenty":-13.517385,"median":-9.253501,"eighty":-6.612231,"marketCap":567056254},{"date":"2026-04-17","current":-3.831779,"twenty":-13.45372,"median":-9.154334,"eighty":-6.50272,"marketCap":549641858},{"date":"2026-04-24","current":-3.642087,"twenty":-13.411276,"median":-9.068084,"eighty":-6.341219,"marketCap":522431865},{"date":"2026-05-01","current":-3.482746,"twenty":-13.38298,"median":-9.030487,"eighty":-6.247466,"marketCap":499575471},{"date":"2026-05-08","current":-3.408766,"twenty":-13.356783,"median":-8.950503,"eighty":-6.042298,"marketCap":488963574},{"date":"2026-05-15","current":-3.051413,"twenty":-13.336336,"median":-8.911801,"eighty":-5.873814,"marketCap":478351676},{"date":"2026-05-22","current":-2.936855,"twenty":-13.312561,"median":-8.871357,"eighty":-5.82388,"marketCap":460393081},{"date":"2026-05-29","current":-2.888254,"twenty":-13.287802,"median":-8.694854,"eighty":-5.684399,"marketCap":452774283},{"date":"2026-06-05","current":-2.579294,"twenty":-13.258302,"median":-8.648626,"eighty":-5.496812,"marketCap":404340495},{"date":"2026-06-12","current":-2.214791,"twenty":-13.222933,"median":-8.630565,"eighty":-5.216676,"marketCap":347199510},{"date":"2026-06-18","current":-2.134948,"twenty":-13.191984,"median":-8.604831,"eighty":-4.257618,"marketCap":334682913},{"date":"2026-06-26","current":-2.207848,"twenty":-13.129203,"median":-8.561886,"eighty":-4.092265,"marketCap":346111110},{"date":"2026-07-02","current":-2.527222,"twenty":-13.033705,"median":-8.501661,"eighty":-3.922831,"marketCap":396177498},{"date":"2026-07-10","current":-2.71121,"twenty":-12.989493,"median":-8.446844,"eighty":-3.831779,"marketCap":425020090},{"date":"2026-07-17","current":-2.509865,"twenty":-12.97623,"median":-8.429698,"eighty":-3.775707,"marketCap":393456498},{"date":"2026-07-24","current":-2.221734,"twenty":-12.962966,"median":-8.408673,"eighty":-3.733139,"marketCap":348287910}],"updateTime":1785019774323},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"UPB\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1117178706","title":"Upstream Bio在EAACI 2026大会上公布新应答者分析：Verekitug在二期VIBRANT试验中为绝大多数CRSwNP患者带来具临床意义的改善","url":"https://stock-news.laohu8.com/highlight/detail?id=1117178706","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1117178706?lang=zh_cn&edition=fundamental","pubTime":"2026-06-14 22:00","pubTimestamp":1781445620,"startTime":"0","endTime":"0","summary":"Upstream Bio公司于2026年欧洲过敏与临床免疫学会大会上，公布了其候选药物Verekitug在二期VIBRANT试验中的最新应答者分析数据。结果显示，在接受Verekitug治疗的患者中，绝大多数患有慢性鼻窦炎伴鼻息肉的参与者，其病情获得了具有临床意义的显著改善。这项深入分析进一步证实了Verekitug作为一款潜在疗法的积极信号。此次在EAACI这一权威国际会议上展示的数据，增强了Verekitug在治疗CRSwNP这一领域的前景。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["UPB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642686892","title":"美国研究综述-Adobe、Caseys General Stores、Oracle","url":"https://stock-news.laohu8.com/highlight/detail?id=2642686892","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642686892?lang=zh_cn&edition=fundamental","pubTime":"2026-06-12 15:34","pubTimestamp":1781249678,"startTime":"0","endTime":"0","summary":"美国研究综述-Adobe、Caseys General Stores、Oracle路透6月12日 - 周五，华尔街证券分析师下调了多家在美国上市公司的评级和目标股价，其中包括Adobe、Caseys General Stores和甲骨文。重点摘要 * Adobe Inc ADBE.O：Baird将目标价从270美元下调至230美元* 凯西百货公司 CASY.O：摩根大通将目标价从719美元上调至975美元* Oracle Corp ORCL.N：汇丰将目标价从345美元下调至316美元以下是路透周五报道的针对美国公司的研究行动摘要。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260612:nL4S42K0GS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4214","LU0648001328.SGD","LU2360106780.USD","SGXZ81514606.USD","BK4548","LU0889566641.SGD","IE0000B7K699.USD","LU1084165304.USD","IE000F7OJYX1.SGD","IE000MB6IJN5.SGD","LU2089283258.USD","LU0861579265.USD","LU0320765059.SGD","LU1894683264.USD","UPB","IE00BQXX3F31.USD","LU0965508806.USD","LU1003077747.HKD","LU2326559502.SGD","IE00B775SV38.USD","BK4097","LU1935043023.USD","LU1934455277.USD","BK4122","IE00BMPRXN33.USD","LU0472753341.HKD","LU0957791311.USD","IE00B3T34201.USD","LU0256863811.USD","LU0963586101.USD","LU0353189763.USD","LU1037948897.HKD","LU1571399168.USD","LU0175139822.USD","LU0109392836.USD","BK4535","LU0965509010.AUD","IE0009356076.USD","LU0965509101.SGD","LU1823568750.SGD","BK4543","LU0348723411.USD","LU1201861249.SGD","LU0345774391.USD","LU0868494708.USD","BK4220","LU0070302665.USD","BK4534","BK4566","LU0476273544.USD","IE000SO60NU8.SGD","LU0985489474.SGD","IE00B5949003.HKD","LU0314106906.USD","CVNA","SGXZ99366536.SGD","LU0342679015.USD","LU1934455194.USD","LU0157215616.USD","LU0719512351.SGD","IE000WAW04H5.SGD","LU1162221912.USD","LU2360032135.SGD","CVNX","LU0208291251.USD","LU0511384066.AUD","IE00B7SZLL34.SGD","LU1046421795.USD","LU1989772840.SGD","LU2065171311.SGD","LU2543165471.USD","SGXZ51526630.SGD","LU0289739343.SGD","IE0009354923.USD","LU0345770993.USD","LU0965509283.SGD","LU0053671581.USD","LU1989772923.USD","LU0006306889.USD","BK4139","LU1267930813.SGD","LU0289960550.SGD","LU0320765646.SGD","ADBE","CVNY","IE00BQXX3C00.GBP","IE00BMPRXQ63.HKD","LU0353189680.USD","LU2065169927.USD","LU1035773651.USD","LU1815333072.USD","LU0433182093.SGD","KTOS","LU1435385759.SGD","LU2236285917.USD","LU1642822529.SGD","LU0942090050.USD","BK4559","LU0106261372.USD","BFH","LU0320765489.SGD","IE00BYQQ9H92.USD","LU0289961442.SGD","LU0949170772.SGD","LU1989764664.SGD","LU1988902786.USD","LU1929549753.HKD","LU0545039389.USD","SG9999011175.SGD","LU1803068979.SGD","LU2357305700.SGD","ORCX","LU1037948541.HKD","LU0878866978.SGD","TENX","IE00BFXG0V08.USD","LU1267930730.SGD","BK4538","LU2264538146.SGD","LU2896262040.SGD","BK4550","LU0012050646.USD","LU2087625088.SGD","SG9999000418.SGD","LU1852331112.SGD","LU0314104364.USD","IE00B5TLWC47.USD","BK4603","LU0210536198.USD","LU2054465674.USD","LU2746668974.SGD","ORCS","LU0444971666.USD","LU1691799644.USD","LU1064131342.USD","LU0130102774.USD","LU1674673691.USD","IE00BMPRXR70.SGD","LU0868494617.USD","LU0980610538.SGD","LU1633808545.USD","LU0056508442.USD","LU1815336760.USD","ORCU","ADBG","LU1623119135.USD","LU1366192091.USD","BK4554","LU1935042215.USD","LU2125154778.USD","LU1244550221.USD","LU0444973449.USD","LU2125154935.USD","IE0002270589.USD","LU0081259029.USD","LU0738911758.USD","LU1244550577.SGD","LU0708995401.HKD","IE00BQXX3D17.EUR","LU2860962120.EUR","LU1674673428.USD","LU2250418816.HKD","LU1720051017.SGD","LU1069347547.HKD","BK4581","IE00BD6J9T35.USD","LU1235294995.USD","LU1429558221.USD","BK4592","LU2746668461.USD","LU1366333091.USD","BK4113","ETSY","MGM","BK4187","LU1778281490.HKD","LU2065170008.USD","LU2237957902.USD","LU0553294199.USD","LU0158827948.USD","LU1720051108.HKD","LU0170899867.USD","ORCL","LU2237438978.USD","CASY","IE000BZT7R73.USD","LU2023251221.USD","LU1244550494.USD","IE00B19Z3B42.SGD","LU2317271919.USD","LU0068578508.USD","LU0069063385.USD","IE00BLSP4452.SGD","LU0133085943.USD","LU0417517546.SGD","BK4150","LU0061474960.USD","BK4528","SG9999003800.SGD","LU1489326972.SGD","LU0109391861.USD","NTRA","PEP","LU2095319765.USD","LU1894683348.USD","BK4178","KTUP","LU0106261612.USD","BK4585","LU0345770308.USD","IE00B19Z3581.USD","LU1506573853.SGD","LU0661504455.SGD","BK4023","BK4516","LU0672654240.SGD","LU1935042991.SGD","LU2065731478.USD","LU2210149790.SGD","LU2458330243.SGD","IE00B3S45H60.SGD","LU1989764748.USD","BK4196","LU0057025933.USD","LU0345774631.USD","LU2065171402.SGD","BK4567","GH","LU0323591593.USD","IE00B19Z9505.USD","LU1712237335.SGD","BK4551","LU0557290698.USD","LU1261432733.SGD","LU2237957811.SGD","LU0198837287.USD","LU1119994496.HKD","LU1934455863.HKD","BK4533","LU1935042488.USD","LU1935043536.SGD","LU2210150020.SGD","LU2089284900.SGD","RH","IE00BBT3K403.USD","BK4177","IE00BLSP4239.USD","LU1548497426.USD","LU2324357040.USD","BK4166","LU0098860793.USD","BK4106","BK4527","LU0082616367.USD","IE0004445239.USD","LU0792757196.USD","LU0889565833.HKD","LU2108987350.USD","LU2458330169.SGD","SG9999001424.SGD","BK4503","BK4504","BK4588","LU0234572021.USD","LU0957808578.USD","LU0054578231.USD","BK4532","LU0234570918.USD","BK4561","IE00BN8TJ469.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123552714","title":"上游生物将在EAACI 2026口头报告环节展示Verekitug针对CRSwNP的二期Vibrant试验额外疗效数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1123552714","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1123552714?lang=zh_cn&edition=fundamental","pubTime":"2026-06-08 19:00","pubTimestamp":1780916426,"startTime":"0","endTime":"0","summary":"上游生物公司计划在即将举行的欧洲过敏与临床免疫学会2026年大会上，通过口头报告形式，进一步公布其候选药物Verekitug用于治疗慢性鼻窦炎伴鼻息肉病的二期Vibrant临床试验的额外疗效数据。此次展示旨在向科学界提供关于该疗法潜力的更深入见解。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","UPB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104582898","title":"Upstream Bio在ATS 2026国际会议上公布Verekitug二期Vibrant试验新数据，显示其改善CRSwNP合并哮喘患者的哮喘症状控制","url":"https://stock-news.laohu8.com/highlight/detail?id=1104582898","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1104582898?lang=zh_cn&edition=fundamental","pubTime":"2026-05-18 23:30","pubTimestamp":1779118224,"startTime":"0","endTime":"0","summary":"Upstream Bio在2026年美国胸科学会国际会议上，公布了其候选药物Verekitug在二期Vibrant临床试验中的最新数据。数据显示，对于同时患有慢性鼻窦炎伴鼻息肉和哮喘的患者，Verekitug在改善哮喘症状控制方面展现出积极效果。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","UPB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121420417","title":"Upstream Bio Inc与Leerink Partners达成普通股销售协议 拟融资1.5亿美元——SEC文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1121420417","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121420417?lang=zh_cn&edition=fundamental","pubTime":"2026-03-27 05:07","pubTimestamp":1774559260,"startTime":"0","endTime":"0","summary":"根据最新提交给美国证券交易委员会的文件显示，生物技术公司Upstream Bio Inc已与Leerink Partners LLC签署销售协议，计划通过公开发行普通股筹集最高1.5亿美元资金。该协议标志着这家专注于炎症性疾病创新疗法研发的企业正式启动资本市场融资通道。此次普通股发售将根据市场条件及其他因素逐步推进，Leerink Partners作为独家销售代理负责承销事宜。作为生物科技领域的新锐力量，Upstream Bio Inc正在开发针对严重炎症性疾病的突破性疗法。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["UPB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162420003","title":"Upstream Bio公布Verekitug三期临床试验战略及2025年第四季度与全年财务业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=1162420003","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162420003?lang=zh_cn&edition=fundamental","pubTime":"2026-03-26 19:03","pubTimestamp":1774523017,"startTime":"0","endTime":"0","summary":"生物制药公司Upstream Bio近日宣布了其核心候选药物Verekitug的三期临床开发战略，并同步披露了2025年第四季度及全年的财务报告。此次公布标志着Verekitug的研发进入关键阶段，公司对其未来市场前景充满信心。财务数据则反映了公司在研发投入与业务运营方面的最新状况。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","UPB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618937974","title":"Upstream Bio, Inc.盘中异动 早盘股价大涨5.30%报8.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2618937974","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618937974?lang=zh_cn&edition=fundamental","pubTime":"2026-03-11 21:40","pubTimestamp":1773236404,"startTime":"0","endTime":"0","summary":"北京时间2026年03月11日21时40分，Upstream Bio, Inc.股票出现异动，股价快速拉升5.30%。截至发稿，该股报8.55美元/股，成交量8.6864万股，换手率0.16%，振幅4.68%。Upstream Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.35%。Upstream Bio, Inc.公司简介：Upstream Bio Inc是一家临床阶段的生物技术公司，开发炎症性疾病的治疗方法，最初专注于严重的呼吸系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311214005a6b84de8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311214005a6b84de8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TSLP","UPB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134831765","title":"Upstream Bio在2026年AAAAI年会上公布Verekitug治疗慢性鼻窦炎伴鼻息肉的2期Vibrant试验补充分析结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1134831765","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1134831765?lang=zh_cn&edition=fundamental","pubTime":"2026-03-01 22:45","pubTimestamp":1772376313,"startTime":"0","endTime":"0","summary":"生物制药公司Upstream Bio于2026年美国过敏、哮喘与免疫学会（AAAAI）年会上，正式发布了其核心候选药物Verekitug在慢性鼻窦炎伴鼻息肉（CRSwNP）患者中开展的2期Vibrant临床试验的补充分析数据。此次公布的分析结果进一步揭示了Verekitug在这一适应症中的治疗潜力与作用机制，为后续临床开发提供了重要依据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["UPB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610340279","title":"BUZZ--美国股票走势-麦当劳、Cloudflare、黄金矿商","url":"https://stock-news.laohu8.com/highlight/detail?id=2610340279","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610340279?lang=zh_cn&edition=fundamental","pubTime":"2026-02-11 20:10","pubTimestamp":1770811840,"startTime":"0","endTime":"0","summary":".N** Robinhood Markets Inc HOOD.O:BUZZ - 加密货币收入令人失望，推动股价盘前走低 nL4N3Z70JI ** Moderna Inc MRNA.O:BUZZ - 因美国食品和药物管理局拒绝审查流感疫苗申请而下滑。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260211:nL4T3Z7118:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2362541513.USD","ROBN","LU2420271590.USD","HOOY","LU1914381329.SGD","AMZN","IE00BYQQ9H92.USD","HL","HOYY","LU1235294995.USD","AU","AMZY","NET","MCD","AMZW","FRSH","QXO","LU2087621335.USD","HOOD","HOOI","HOOW","HOOZ","LU2362540622.SGD","AZYY","HUM","CDE","AVTR","HOOG","IE00BFSS7M15.SGD","MRNA","LU2092627202.USD","AMZU","LU1868837300.USD","NEM","MAT","AMZZ","GILD","UPB","AMZD","CURB","BK4543","HOOX","LU2097829019.USD","LU2592432038.USD","USAW.SI","HODU","LYFT","BETA","IE00B3S45H60.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610939471","title":"BUZZ-实验性哮喘药物在中期研究中显示出前景，上游生物一跃而起","url":"https://stock-news.laohu8.com/highlight/detail?id=2610939471","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610939471?lang=zh_cn&edition=fundamental","pubTime":"2026-02-11 19:30","pubTimestamp":1770809409,"startTime":"0","endTime":"0","summary":"由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260211:nL4S3Z70WS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["UPB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170657934","title":"Upstream Bio公布Verekitug治疗重症哮喘II期Valiant试验积极顶线结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1170657934","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1170657934?lang=zh_cn&edition=fundamental","pubTime":"2026-02-11 19:01","pubTimestamp":1770807683,"startTime":"0","endTime":"0","summary":"生物制药公司Upstream Bio近日宣布，其用于治疗重症哮喘的在研药物Verekitug，在II期Valiant临床试验中取得了积极的顶线结果。\n该试验数据表明，Verekitug在主要疗效终点上表现出显著优势，达到了预设的统计学标准。这一积极结果标志着Verekitug在治疗重症哮喘这一未满足巨大医疗需求的领域取得了重要进展，为后续的临床开发奠定了坚实基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["UPB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610609525","title":"Upstream Bio, Inc.盘中异动 大幅上涨5.07%报27.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2610609525","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610609525?lang=zh_cn&edition=fundamental","pubTime":"2026-02-11 01:34","pubTimestamp":1770744859,"startTime":"0","endTime":"0","summary":"北京时间2026年02月11日01时34分，Upstream Bio, Inc.股票出现波动，股价急速拉升5.07%。截至发稿，该股报27.45美元/股，成交量17.7095万股，换手率0.33%，振幅5.86%。Upstream Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.14%。Upstream Bio, Inc.公司简介：Upstream Bio Inc是一家临床阶段的生物技术公司，开发炎症性疾病的治疗方法，最初专注于严重的呼吸系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260211013419a6eb6aad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260211013419a6eb6aad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TSLP","BK4139","UPB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609058293","title":"Upstream Bio, Inc.盘中异动 早盘股价大跌5.03%报29.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2609058293","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609058293?lang=zh_cn&edition=fundamental","pubTime":"2026-02-04 23:15","pubTimestamp":1770218156,"startTime":"0","endTime":"0","summary":"北京时间2026年02月04日23时15分，Upstream Bio, Inc.股票出现波动，股价急速下跌5.03%。截至发稿，该股报29.24美元/股，成交量9.3707万股，换手率0.17%，振幅4.97%。Upstream Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.65%。Upstream Bio, Inc.公司简介：Upstream Bio Inc是一家临床阶段的生物技术公司，开发炎症性疾病的治疗方法，最初专注于严重的呼吸系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204231556953fd698&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204231556953fd698&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","UPB","TSLP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2607708320","title":"Upstream Bio, Inc.盘中异动 股价大跌5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607708320","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607708320?lang=zh_cn&edition=fundamental","pubTime":"2026-01-29 00:33","pubTimestamp":1769618031,"startTime":"0","endTime":"0","summary":"北京时间2026年01月29日00时33分，Upstream Bio, Inc.股票出现波动，股价大幅下挫5.12%。Upstream Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.84%。Upstream Bio, Inc.公司简介：Upstream Bio Inc是一家临床阶段的生物技术公司，开发炎症性疾病的治疗方法，最初专注于严重的呼吸系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260129003351a6b8183e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260129003351a6b8183e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TSLP","UPB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2605000402","title":"Upstream Bio, Inc.盘中异动 临近午盘股价大跌5.06%报30.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2605000402","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605000402?lang=zh_cn&edition=fundamental","pubTime":"2026-01-24 00:50","pubTimestamp":1769187042,"startTime":"0","endTime":"0","summary":"北京时间2026年01月24日00时50分，Upstream Bio, Inc.股票出现异动，股价大幅下挫5.06%。截至发稿，该股报30.18美元/股，成交量8.2757万股，换手率0.15%，振幅3.90%。Upstream Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.45%。Upstream Bio, Inc.公司简介：Upstream Bio Inc是一家临床阶段的生物技术公司，开发炎症性疾病的治疗方法，最初专注于严重的呼吸系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260124005042953e20b8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260124005042953e20b8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TSLP","BK4139","UPB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2601524458","title":"Upstream Bio, Inc.盘中异动 股价大跌5.06%报25.70美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2601524458","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601524458?lang=zh_cn&edition=fundamental","pubTime":"2026-01-06 02:05","pubTimestamp":1767636308,"startTime":"0","endTime":"0","summary":"北京时间2026年01月06日02时05分，Upstream Bio, Inc.股票出现波动，股价快速下跌5.06%。截至发稿，该股报25.70美元/股，成交量20.6153万股，换手率0.38%，振幅6.10%。Upstream Bio, Inc.股票所在的生物技术行业中，整体跌幅为1.61%。Upstream Bio, Inc.公司简介：Upstream Bio Inc是一家临床阶段的生物技术公司，开发炎症性疾病的治疗方法，最初专注于严重的呼吸系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026010602050997a10fd5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026010602050997a10fd5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","UPB","TSLP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2594233385","title":"Upstream Bio, Inc.盘中异动 早盘急速上涨5.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2594233385","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2594233385?lang=zh_cn&edition=fundamental","pubTime":"2025-12-24 23:12","pubTimestamp":1766589144,"startTime":"0","endTime":"0","summary":"北京时间2025年12月24日23时12分，Upstream Bio, Inc.股票出现异动，股价快速拉升5.31%。Upstream Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.51%。其相关个股中，Indaptus Therapeutics, Inc.、Dermata Therapeutics Inc C/Wts 、Humacyte Inc C/Wts 27/08/2026 涨幅较大，Dermata Therapeutics, Inc.、Indaptus Therapeutics, Inc.、Citius Pharmaceuticals, Inc.较为活跃，换手率分别为1756.82%、1126.59%、54.08%，振幅较大的相关个股有Briacell Therapeutics Corp C/Wts 26/02/2026、Citius Pharmaceuticals, Inc.、Dermata Therapeutics, Inc.，振幅分别为62.58%、52.88%、23.04%。Upstream Bio, Inc.公司简介：Upstream Bio Inc是一家临床阶段的生物技术公司，开发炎症性疾病的治疗方法，最初专注于严重的呼吸系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251224231225a6cae61c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251224231225a6cae61c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","UPB","TSLP"],"isVideo":false,"video":null,"gpt_icon":1}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":17,"code":"91000000","status":"200"}]}}